Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection

This publication has 16 references indexed in Scilit:

• Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin
  Vaccine, 1996
• Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine
  Vaccine, 1994
• Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes
  Vaccine, 1993
• Cross‐protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules
  European Journal of Immunology, 1991
• Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB
  Vaccine, 1989
• The biosynthesis of secretory component and its role in the transepithelial transport of IgA dimer
  Immunology Today, 1985
• Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity
  European Journal of Immunology, 1984
• IMMUNITY TO INFLUENZA IN MAN
  Annual Review of Microbiology, 1983
• Polymeric IgA is Complexed with Secretory Component (SC) on the Surface of Human Intestinal Epithelial Cells
  Scandinavian Journal of Immunology, 1978
• Secretory component of epithelial cells is a surface receptor for polymeric immunoglobulins.
  The Journal of Experimental Medicine, 1978